National Health Services (Regulation and Coordination) Secretary Ayub Shaikh said that DRAP had given three proposals: reference pricing, cost plus basis pricing system and average pricing system and asked the industry and trade bodies to give their input.
According to industry sources, Pharma Bureau
Representative said that due to inconsistent policies and interim arrangements, multinational companies are moving out of Pakistan.
The source said that Pharma Bureau would like to go for a reference pricing as it would be acceptable to the people and the government.
The source further said that controlled and de-controlled list should be as per requirement and only a small number of drug prices should be controlled.
Speaking on behalf of importers, an official of Pakistan Chemists and Druggists’ Association (PCDA) said the association is all for reference pricing.
